Effect of Alpha-Linolenic Acid Supplementation on Cardiovascular Disease Risk Profile in Individuals with Obesity or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Maffetone, 2016, Overfat and underfat: new terms and definitions long overdue, Front. Public. Health., 4, 279 Obesity and overweight. Fact Sheet N_311. WHO, Geneva. Accessed May 10, 2018. Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. 2000, Obesity: preventing and managing the global epidemic. Report of a WHO Consultation, World Health Organ, Tech. Rep. Ser., 894 Vekic, 2019, Obesity and dyslipidemia, Metabolism, 92, 71, 10.1016/j.metabol.2018.11.005 Seravalle, 2017, Obesity and hypertension, Pharmacol. Res., 122, 1, 10.1016/j.phrs.2017.05.013 Cox, 2015, Obesity, inflammation, and the gut microbiota, Lancet Diabetes Endocrinol, 3, 207, 10.1016/S2213-8587(14)70134-2 Roth, 2020, Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study, J. Am. Coll. Cardiol., 76, 2982, 10.1016/j.jacc.2020.11.010 Pirillo, 2021, Global epidemiology of dyslipidaemias, Nat. Rev. Cardiol., 18, 689, 10.1038/s41569-021-00541-4 Kenchaiah, 2002, Obesity and the risk of heart failure, N. Engl. J. Med., 347, 305, 10.1056/NEJMoa020245 Katta, 2021, Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging, Curr. Probl. Cardiol., 46, 10.1016/j.cpcardiol.2020.100655 Lavie, 2017, Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise, J. Am. Coll. Cardiol., 70, 2022, 10.1016/j.jacc.2017.09.002 Powell-Wiley, 2021, Obesity and cardiovascular disease: a scientific statement from the American Heart Association, Circulation, 143, e984, 10.1161/CIR.0000000000000973 Koliaki, 2019, Obesity and cardiovascular disease: revisiting an old relationship, Metabolism, 92, 98, 10.1016/j.metabol.2018.10.011 Fiuza-Luces, 2018, Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors, Nat. Rev. Cardiol., 15, 731, 10.1038/s41569-018-0065-1 Salas-Salvadó, 2018, Mediterranean diet and cardiovascular disease prevention: what do we know?, Prog. Cardiovasc. Dis., 61, 62, 10.1016/j.pcad.2018.04.006 Xi, 2017, Relationship of alcohol consumption to All-Cause, cardiovascular, and cancer-related mortality in U.S. adults, J. Am. Coll. Cardiol., 70, 913, 10.1016/j.jacc.2017.06.054 Le Bras, 2018, Public health: light smoking and CVD risk, Nat. Rev. Cardiol., 15, 136, 10.1038/nrcardio.2018.10 Abdelhamid, 2020, Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 3, CD003177 Skulas-Ray, 2019, Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association, Circulation, 140, e673, 10.1161/CIR.0000000000000709 Stark, 2016, Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults, Prog. Lipid. Res., 63, 132, 10.1016/j.plipres.2016.05.001 Barceló-Coblijn, 2009, Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels, Prog. Lipid. Res., 48, 355, 10.1016/j.plipres.2009.07.002 Kim, 2014, α-linolenic acid: nutraceutical, pharmacological and toxicological evaluation, Food Chem. Toxicol., 70, 163, 10.1016/j.fct.2014.05.009 Greupner, 2018, Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status, Food Funct, 9, 1587, 10.1039/C7FO01809F Fekete, 2015, Long-chain polyunsaturated fatty acid status in obesity: a systematic review and meta-analysis, Obes. Rev., 16, 488, 10.1111/obr.12280 Aglago, 2017, Association between serum phospholipid fatty acid levels and adiposity in Mexican women, J. Lipid. Res., 58, 1462, 10.1194/jlr.P073643 Naghshi, 2021, Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies, BMJ, 375, n2213, 10.1136/bmj.n2213 Yue, 2021, Effects of α-linolenic acid intake on blood lipid profiles: a systematic review and meta-analysis of randomized controlled trials, Crit. Rev. Food Sci. Nutr., 61, 2894, 10.1080/10408398.2020.1790496 de Abreu, 2022, Effects of supplementation with vegetable sources of alpha-linolenic acid (ALA) on inflammatory markers and lipid profile in individuals with chronic kidney disease: a systematic review and meta-analysis, Clin. Nutr., 41, 1434, 10.1016/j.clnu.2022.02.013 Su, 2018, Effect of dietary alpha-linolenic acid on blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials, Eur. J. Nutr., 57, 877, 10.1007/s00394-017-1386-2 Ren, 2016, Effect of flaxseed intervention on inflammatory marker C-reactive protein: a systematic review and meta-analysis of randomized controlled trials, Nutrients, 8, 136, 10.3390/nu8030136 Rahimlou, 2019, Effects of flaxseed interventions on circulating inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials, Adv. Nutr., 10, 1108, 10.1093/advances/nmz048 Kamoun, 2021, Moderate walnut consumption improved lipid profile, steroid hormones and inflammation in trained elderly men: a pilot study with a randomized controlled trial, Biol. Sport., 38, 245, 10.5114/biolsport.2020.97676 Moher, 2009, PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 Zhang, 2022, Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trials, J. Am. Heart Assoc., 11 Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Cumpston, 2019, Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Database Syst. Rev., 10, ED000142 Follmann, 1992, Variance imputation for overviews of clinical trials with continuous response, J. Clin. Epidemiol., 45, 769, 10.1016/0895-4356(92)90054-Q Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med. Res. Methodol., 5, 13, 10.1186/1471-2288-5-13 Balk, 2012 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ., 327, 557, 10.1136/bmj.327.7414.557 Hutchins, 2013, Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study, Nutr. Res., 33, 367, 10.1016/j.nutres.2013.02.012 Katz, 2012, Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial, J. Am. Coll. Nutr., 31, 415, 10.1080/07315724.2012.10720468 Nelson, 2007, Inflammatory markers are not altered by an eight week dietary alpha-linolenic acid intervention in healthy abdominally obese adult males and females, Cytokine, 38, 101, 10.1016/j.cyto.2007.05.010 Nieman, 2012, Chia seed supplementation and disease risk factors in overweight women: a metabolomics investigation, J. Altern. Complement. Med., 18, 700, 10.1089/acm.2011.0443 Rock, 2017, Walnut consumption in a weight reduction intervention: effects on body weight, biological measures, blood pressure and satiety, Nutr. J., 16, 76, 10.1186/s12937-017-0304-z de Oliveira, 2017, Unsaturated fatty acids improve atherosclerosis markers in obese and overweight non-diabetic elderly patients, Obes. Surg., 27, 2663, 10.1007/s11695-017-2704-8 Faintuch, 2011, Systemic inflammation and carotid diameter in obese patients: pilot comparative study with flaxseed powder and cassava powder, Nutr. Hosp., 26, 208 Kruse, 2020, Dietary rapeseed oil supplementation reduces hepatic steatosis in obese men-a randomized controlled trial, Mol. Nutr. Food Res., 64, 10.1002/mnfr.202000419 Machado, 2015, Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents, Nutrition, 31, 90, 10.1016/j.nut.2014.05.002 Ahmadniay Motlagh, 2021, Effect of flaxseed consumption on central obesity, serum lipids, and adiponectin level in overweight or obese women: a randomised controlled clinical trial, Int. J. Clin. Pract., 75, 10.1111/ijcp.14592 Hajiahmadi, 2020, Effect of flaxseed oil on glycemic control and inflammatory markers in overweight adults with pre-diabetes: a double-blind randomized controlled clinical trial, J. Herb. Med., 24 Shareghfarid, 2022, The effect of flaxseed oil supplementation on body composition and inflammation indices in overweight adults with pre-diabetes, Nutr. Metab. Insights., 15, 10.1177/11786388221090083 Jamilian, 2019, Effects of flaxseed oil omega-3 fatty acids supplementation on regression and metabolic status in endometrial hyperplasia: a randomized, double-blind, placebo-controlled trial, Int. J. Prev. Med., 10, 61, 10.4103/ijpvm.IJPVM_73_18 Egert, 2007, Effects of controlled diets enriched with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on soluble adhesion molecules and endothelin-1 concentrations in healthy volunteers, Curr. Top. Nutraceutical. Res., 5, 189 Baxheinrich, 2012, Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome, Br. J. Nutr., 108, 682, 10.1017/S0007114512002875 Ndanuko, 2018, Effect of individualised dietary advice for weight loss supplemented with walnuts on blood pressure: the HealthTrack study, Eur. J. Clin. Nutr., 72, 894, 10.1038/s41430-018-0123-0 Hwang, 2019, Daily walnut intake improves metabolic syndrome status and increases circulating adiponectin levels: randomized controlled crossover trial, Nutr. Res. Pract., 13, 105, 10.4162/nrp.2019.13.2.105 Eriksen, 2020, Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial, Am. J. Clin. Nutr., 111, 864, 10.1093/ajcn/nqaa026 Joris, 2019, Effect of Α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: a randomized placebo-controlled trial in untreated (Pre)hypertensive subjects, Atherosclerosis, 287, e33, 10.1016/j.atherosclerosis.2019.06.097 Egert, 2014, Effects of an energy-restricted diet rich in plant-derived α-linolenic acid on systemic inflammation and endothelial function in overweight-to-obese patients with metabolic syndrome traits, Br. J. Nutr., 112, 1315, 10.1017/S0007114514002001 Joris, 2020, Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: a randomized placebo-controlled trial in untreated (pre-)hypertensive individuals, Clin. Nutr., 39, 2413, 10.1016/j.clnu.2019.11.032 Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 Ridker, 2018, Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?, Eur. Heart. J., 39, 4109, 10.1093/eurheartj/ehy723 Goswami, 2021, Management of inflammation in cardiovascular diseases, Pharmacol. Res., 173, 10.1016/j.phrs.2021.105912 Ren, 2007, Anti-inflammatory effect of alpha-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NF-kappaB and mitogen-activated protein kinase pathways, J. Agric. Food Chem., 55, 5073, 10.1021/jf0702693 Baranowski, 2012, Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats, Cytokine, 59, 382, 10.1016/j.cyto.2012.04.004 Mahmudiono, 2022, The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized clinical trials, Phytother. Res., 36, 3766, 10.1002/ptr.7566 Li, 2023, Effect of flaxseed supplementation on blood pressure: a systematic review, and dose-response meta-analysis of randomized clinical trials, Food Funct, 14, 675, 10.1039/D2FO02566C Alwosais, 2021, Chia seed (Salvia hispanica L.) supplementation to the diet of adults with type 2 diabetes improved systolic blood pressure: a randomized controlled trial, Nutr. Health., 27, 181, 10.1177/0260106020981819 Li, 2020, Effects of walnut intake on blood pressure: a systematic review and meta-analysis of randomized controlled trials, Phytother. Res., 34, 2921, 10.1002/ptr.6740 Malmir, 2022, The effect of walnut consumption on cardiometabolic profiles of individuals with abnormal glucose homoeostasis: a systematic review and meta-analysis of clinical trials, Br. J. Nutr., 128, 1037, 10.1017/S0007114521004414 Hashimoto, 2020, Intake of alpha-linolenic acid-rich Perilla frutescens Leaf Powder decreases home blood pressure and serum oxidized low-density lipoprotein in Japanese adults, Molecules, 25, 10.3390/molecules25092099 Oelrich, 2013, Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults, Nutr. Metab. Cardiovasc. Dis., 23, 350, 10.1016/j.numecd.2011.06.003 Basu, 2018, Mechanism of increased LDL (low-density lipoprotein) and decreased triglycerides with SGLT2 (sodium-glucose cotransporter 2) inhibition, Arterioscler. Thromb. Vasc. Biol., 38, 2207, 10.1161/ATVBAHA.118.311339 Wright, 2011, Biology of human sodium glucose transporters, Physiol. Rev., 91, 733, 10.1152/physrev.00055.2009 Neal, 2017, Canagliflozin and cardiovascular and renal events in type 2 diabetes, N. Engl. J. Med., 377, 2099 Xie, 2022, Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice, Curr. Res. Physiol., 5, 232, 10.1016/j.crphys.2022.05.003 Zinman, 2015, Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes, N. Engl. J. Med., 373, 2117, 10.1056/NEJMoa1504720 Aryal, 2019, ANGPTL4 in metabolic and cardiovascular disease, Trends. Mol. Med., 25, 723, 10.1016/j.molmed.2019.05.010 Georgiadi, 2010, Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress, Circ. Res., 106, 1712, 10.1161/CIRCRESAHA.110.217380 Stitziel, 2016, Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease, N. Engl. J. Med., 374, 1134, 10.1056/NEJMoa1507652 Filgueiras, 2020, Vitamin D status, oxidative stress, and inflammation in children and adolescents: a systematic review, Crit. Rev. Food Sci. Nutr., 60, 660, 10.1080/10408398.2018.1546671 Cai, 2022, Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis, Cell. Host. Microbe., 30, 289, 10.1016/j.chom.2022.02.004